63 related articles for article (PubMed ID: 34291647)
1. Current and potential biomarkers in gastric cancer: a critical review of the literature.
de Mello RA; Amaral GA; Neves NM; Lippo EG; Parini F; Xu S; Tolia M; Charalampakis N; Tadokoro H; Castelo-Branco P; Zhu J
Future Oncol; 2021 Sep; 17(25):3383-3396. PubMed ID: 34291647
[TBL] [Abstract][Full Text] [Related]
2. Identification of Gastric Cancer Biomarkers Using 1H Nuclear Magnetic Resonance Spectrometry.
Ramachandran GK; Yong WP; Yeow CH
PLoS One; 2016; 11(9):e0162222. PubMed ID: 27611679
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnosis for personalized target therapy in gastric cancer.
Cho JY
J Gastric Cancer; 2013 Sep; 13(3):129-35. PubMed ID: 24156032
[TBL] [Abstract][Full Text] [Related]
4. Predictive biomarkers in gastric cancer.
Röcken C
J Cancer Res Clin Oncol; 2023 Jan; 149(1):467-481. PubMed ID: 36260159
[TBL] [Abstract][Full Text] [Related]
5. Molecular and Circulating Biomarkers of Gastric Cancer.
Jelski W; Mroczko B
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886934
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer treatment: recent progress and future perspectives.
Guan WL; He Y; Xu RH
J Hematol Oncol; 2023 May; 16(1):57. PubMed ID: 37245017
[TBL] [Abstract][Full Text] [Related]
7. Radiomics in precision medicine for gastric cancer: opportunities and challenges.
Chen Q; Zhang L; Liu S; You J; Chen L; Jin Z; Zhang S; Zhang B
Eur Radiol; 2022 Sep; 32(9):5852-5868. PubMed ID: 35316364
[TBL] [Abstract][Full Text] [Related]
8. Global Incidence and Mortality of Gastric Cancer, 1980-2018.
Wong MCS; Huang J; Chan PSF; Choi P; Lao XQ; Chan SM; Teoh A; Liang P
JAMA Netw Open; 2021 Jul; 4(7):e2118457. PubMed ID: 34309666
[TBL] [Abstract][Full Text] [Related]
9. Gastric Cancer: Emerging Trends in Prevention, Diagnosis, and Treatment.
Norwood DA; Montalvan-Sanchez E; Dominguez RL; Morgan DR
Gastroenterol Clin North Am; 2022 Sep; 51(3):501-518. PubMed ID: 36153107
[TBL] [Abstract][Full Text] [Related]
10. Advances in screening and detection of gastric cancer.
Xia JY; Aadam AA
J Surg Oncol; 2022 Jun; 125(7):1104-1109. PubMed ID: 35481909
[TBL] [Abstract][Full Text] [Related]
11. Identification of early diagnostic biomarkers via WGCNA in gastric cancer.
Rezaei Z; Ranjbaran J; Safarpour H; Nomiri S; Salmani F; Chamani E; Larki P; Brunetti O; Silvestris N; Tavakoli T
Biomed Pharmacother; 2022 Jan; 145():112477. PubMed ID: 34864309
[TBL] [Abstract][Full Text] [Related]
12. The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer.
Xu Y; Zhang P; Zhang K; Huang C
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188634. PubMed ID: 34656687
[TBL] [Abstract][Full Text] [Related]
13. Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy.
Cai H; Li M; Deng R; Wang M; Shi Y
Biomark Res; 2022 Aug; 10(1):67. PubMed ID: 36042469
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological Trends and Future Perspectives of Gastric Cancer in Eastern Asia.
Sekiguchi M; Oda I; Matsuda T; Saito Y
Digestion; 2022; 103(1):22-28. PubMed ID: 34515086
[TBL] [Abstract][Full Text] [Related]
15. The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration.
Ooki A; Yamaguchi K
Gastric Cancer; 2021 Nov; 24(6):1169-1183. PubMed ID: 34398359
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of the role of PR/SET domain 14 in gastric cancer.
Li X; Wang C; Wang Y; Chen X; Li Z; Wang J; Liu Y
BMC Cancer; 2024 Jun; 24(1):685. PubMed ID: 38840106
[TBL] [Abstract][Full Text] [Related]
17. [Screening of differentially expressed genes in gastric cancer based on GEO database and function and pathway enrichment analysis].
Liang Y; Lai Y; Yuan Y; Yuan W; Zhang X; Zhang B; Lu Z
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):605-616. PubMed ID: 38597453
[TBL] [Abstract][Full Text] [Related]
18. Construction of an immune-related gene signature for overall survival prediction and immune infiltration in gastric cancer.
Ma XT; Liu X; Ou K; Yang L
World J Gastrointest Oncol; 2024 Mar; 16(3):919-932. PubMed ID: 38577455
[TBL] [Abstract][Full Text] [Related]
19. Construct dysregulated miRNA-mRNA interaction networks to conjecture possible pathogenesis for Stomach adenocarcinomas.
Peng S; Zhang H; Song G; Zhu J; Zhang S; Liu C; Gao F; Yang H; Zhu W
Cancer Biomark; 2024; 39(3):197-210. PubMed ID: 38108345
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of PD-L1 and infiltrated immune cells in the gastric adenocarcinoma microenvironment.
Quan Q; Guo L; Huang L; Liu Z; Guo T; Shen Y; Ding S; Liu C; Cao L
Medicine (Baltimore); 2023 Dec; 102(48):e36323. PubMed ID: 38050283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
